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Abstract
Vehicular traffic polycyclic aromatic hydrocarbons (PAHs) have been associated with breast 
cancer incidence in epidemiologic studies, including our own. Because PAHs damage DNA by 
forming adducts and oxidative lesions, genetic polymorphisms that alter DNA repair capacity may 
modify associations between PAH-related exposures and breast cancer risk. Our goal was to 
examine the association between vehicular traffic exposure and breast cancer incidence within 
strata of a panel of nine biologically plausible nucleotide excision repair (NER) and base excision 
repair (BER) genotypes. Residential histories of 1,508 cases and 1,556 controls were assessed in 
the Long Island Breast Cancer Study Project between 1996 and 1997 and used to reconstruct 
residential traffic exposures to benzo[a]pyrene, as a proxy for traffic-related PAHs. Likelihood 
Correspondence to: Irina Mordukhovich, Exposure, Epidemiology and Risk, Program, Department of Environmental Health, 
Harvard T.H. Chan School of Public Health, Landmark Center, 401 Park Dr., Boston, MA 02215, USA, Tel.: [617-384-8754], 
imordukh@hsph.harvard.edu.
*Deceased as of 10/7/2012.
HHS Public Access
Author manuscript
Int J Cancer. Author manuscript; available in PMC 2017 July 15.
Published in final edited form as:













ratio tests from adjusted unconditional logistic regression models were used to assess 
multiplicative interactions. A gene-traffic interaction was evident (p = 0.04) for ERCC2 (Lys751); 
when comparing the upper and lower tertiles of 1995 traffic exposure estimates, the odds ratio 
(95% confidence interval) was 2.09 (1.13, 3.90) among women with homozygous variant alleles. 
Corresponding odds ratios for 1960–1990 traffic were also elevated nearly 2–3-fold for XRCC1 
(Arg194Trp), XRCC1(Arg399Gln) and OGG1(-Ser326Cys), but formal multiplicative interaction 
was not evident. When DNA repair variants for ERCC2, XRCC1 and OGG1 were combined, 
among women with 4–6 variants, the odds ratios were 2.32 (1.22, 4.49) for 1995 traffic and 2.96 
(1.06, 8.21) for 1960–1990 traffic. Our study is first to report positive associations between traffic-
related PAH exposure and breast cancer incidence among women with select biologically plausible 
DNA repair genotypes.
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Breast cancer is the most common malignancy among women in the United States,1 
northern Europe, England, Canada, and Australia.2 Polycyclic aromatic hydrocarbons 
(PAHs) are incomplete combustion by-products found in air pollution.3,4 In particular, 
vehicular traffic is a major contributor to ambient PAH levels, especially near cities.5,6 PAHs 
are confirmed human lung carcinogens and potent mammary carcinogens in animal models.4 
PAH-DNA adducts7–9 and air pollution exposure10,11 have been associated with breast 
cancer in prior epidemiological studies, including in our own.8,12
PAHs damage DNA by forming bulky adducts13 and by inducing oxidative stress.4 If 
unrepaired, PAH-induced DNA damage can lead to somatic mutations in tumor suppressor 
genes or proto-oncogenes, thereby contributing to carcinogenesis.7 Hence, genetic 
polymorphisms that alter DNA repair capacity may modify associations between PAH-
related exposures and breast cancer risk.14 Of the four major DNA repair pathways,15 
nucleotide excision repair (NER) and base excision repair (BER) are most likely to mend 
PAH-induced DNA damage, since the NER pathway repairs bulky DNA adducts and the 
BER pathway repairs oxidative DNA damage.13,16,17
The few studies conducted to date suggest that polymorphisms in NER and BER genes may 
interact with PAH-related exposures, such as cigarette smoke or PAH-DNA adducts, with 
respect to breast cancer risk.18–21 However, the impact of DNA repair polymorphisms on the 
relationship between air pollution and breast cancer has not been evaluated previously. Our 
study examines the association between residential vehicular traffic exposure and breast 
cancer incidence within strata of NER and BER genotypes, using the resources of a 
population-based investigation.22 Findings of this first study to examine these associations, 
if confirmed, may increase understanding of breast cancer etiology and help identify women 
who may be particularly susceptible to the carcinogenic effects of traffic pollution on the 
breast.
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Our study used resources from the case-control component of the Long Island Breast Cancer 
Study Project (LIBCSP), a population-based investigation conducted among adult women 
(ages 20–98) residing in Nassau and Suffolk counties in Long Island, NY.22 This study was 
approved by the institutional review boards of all participating institutions.
Study population
Case participants were diagnosed with a first primary invasive or in situ breast cancer 
between July 1996 and August 1997, and were recruited via rapid case ascertainment 
through contact with the pathology departments of local hospitals. Control participants were 
women with no personal history of breast cancer. Controls under age 65 were identified 
using random digit dialing,23 and those aged 65 years or older were identified via Health 
Care Finance Administration rosters. Control participants were frequency matched based on 
the expected age distribution among the cases. In total, 1,508 cases and 1,556 controls 
(82.1% and 62.7% of eligible participants, respectively) completed the case-control study 
interview. Most participants were post-menopausal and white, which is consistent with the 
underlying racial distribution of the study counties at the time of data collection.22
Previous studies using LIBCSP resources reported positive associations between several 
PAH-related exposures and overall breast cancer incidence: elevated PAH-DNA adducts in 
mononuclear cells,8 long-term residential exposure to environmental tobacco smoke,24 
increased consumption of grilled/smoked meat,25 indoor stove and fireplace use,26 and the 
top 5% of long-term residential vehicular traffic exposures, compared with exposures below 
the median.12
Study questionnaire
Trained interviewers administered a 2-hr structured questionnaire in participants’ homes.22 
The questionnaire evaluated detailed information regarding a wide range of factors used in 
our analyses, including lifetime residential history, demographic characteristics, reproductive 
and medical history, and body size.22
Traffic exposure assessment
Participants’ historical residential traffic-related PAH exposures were reconstructed using a 
model which incorporated lifetime residential history in the study counties, historical U.S. 
vehicular PAH emissions and roadway-specific traffic patterns, local meteorological data, 
pollutant dispersion factors, and excess emissions at intersections.27–29 In a validation study, 
the model accurately predicted residential soil PAH measurements as well as participants’ 
levels of PAH-DNA adducts in mononuclear cells.27
Exposure estimates were reconstructed for the years 1960–1990 and 1995. Some 
participants moved to the study area after 1960, and others had periods of incomplete 
address data while residing in the study counties. Hence, an exposure surrogate was 
developed to estimate pre-arrival exposures, with variance added during multiple imputation 
(MI), and missing post-arrival exposures were calculated via MI based on participants’ 
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known residential addresses.29,34 The percentage of imputation was restricted to ≤20% of 
total 1960–1990 exposure.12 Thus, the imputed portion of the dose was relatively minor, 
with an average of <10% among those with any imputed exposure information. Our research 
group also previously conducted sensitivity analyses in order to evaluate the impact of 
imputation on our study results. One sensitivity analysis restricted the imputation percentage 
to 0%, 20% or 30%. Another sensitivity analysis examined two imputation methods: (1) 
based on exposures at participants’ known residences (before or after the missing exposure 
period) and (2) according to census place (i.e., city, town or village, which was often known 
even when a woman’s address was incomplete). As previously reported,12 these sensitivity 
analyses did not meaningfully alter results for the association between traffic PAH exposure 
and breast cancer risk. Hence, we are confident that imputing <20% of exposure did not 
introduce spurious findings. For 1995 exposure, only women with complete, unimputed 
exposure information were included in regressions [denoted as a complete case analysis 
(CCA)].
Because our exposure model predicted benzo[a]pyrene levels as a surrogate for all traffic 
PAHs, exposure estimates were normalized to the mean exposure level for the year 1995 and 
presented as relative units of average annual exposure during 1995.27,29 Exposures in the 
year 1995 ranged between 0.02 and 31 relative units (mean = 1.0), and cumulative exposures 
during the years 1960–1990 (20% MI) ranged between 16 and 5467 relative units of average 
annual exposure in 1995 (mean = 212)12. Most LIBCSP participants had lived in their 
current home for at least 15 years,22 and previously reported correlations between exposures 
in 1995 and 1960–1990 were strong.12
Blood sample collection and DNA extraction
Study interviewers, who were either nurses or certified phlebotomists, obtained a 40 mL 
non-fasting blood sample at the study visit from 73% of case and 73% of control 
participants.22 Blood samples were collected in EDTA-treated tubes and shipped overnight 
to a laboratory in Columbia University, where they were aliquoted and stored in −80°C 
freezers using participants’ randomly assigned study identification numbers.22
Mononuclear cells were separated from whole blood using Ficoll (Sigma Chemical Co., St. 
Louis, MO), washed twice with phosphate-buffered saline, and frozen until DNA isolation.22 
DNA was extracted using phenol and chloroform isoamyl alcohol, followed by RNase and 
proteinase K treatment.20,22
Genotyping
Our study evaluated a panel of single nucleotide polymorphisms (SNPs) in the following 
genes, which were selected because of their biologic plausibility for potentially modifying 
the association between traffic and breast cancer incidence: excision repair cross-
complementing groups 1 (ERCC1, 8092C/A [rs3212986]), 8-oxoguanine DNA glycosylase 
1 (OGG1, Ser326Cys [rs1052133]), 2 (ERCC2, Lys751Gln [rs13181] and Asp312Asn 
[rs1799793]), 4 (ERCC4, Arg415Gln [rs1800067]), and 5 (ERCC5, Asp1104His [rs17655]) 
X-ray repair cross complementing Group 1 (XRCC1, Arg399Gln [rs25487] and Arg194Trp 
[rs1799782]), and xeroderma pigmentosum group A (XPA, –4A/G [rs1800975]). These 
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SNPs were previously found to be in Hardy-Weinberg equilibrium among LIBCSP 
controls.18,20,21,30 Genotyping was completed for 91–97% of women who donated a blood 
sample, depending on the polymorphism (n = 2,050–2,177); missing genotype data was 
mainly due to insufficient DNA available for assays.18,20,21,30
Several high-throughput methods were used by the LIBCSP study investigators for 
genotyping the DNA repair pathway polymorphisms. SNPs in ERCC1, XRCC1, OGG1 and 
ERCC2 (Lys751Gln) were genotyped using fluorescence polarization (FP),18,20,21,30 which 
identifies the polymorphic base using a template-directed, dye-labeled dideoxynucleotide.31 
SNPs in XPA and ERCC2 (Asp312Asn) were genotyped using the Taqman assay (Applied 
Biosystems, Foster City, CA),18 which uses fluorogenic oligonucleotide reverse probes for 
allele recognition. SNPs in ERCC4 and ERCC5 were genotyped using Sequenom’s high-
throughput matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, 
chosen for its ability to multiplex (BioServe Biotechnologies, Laurel, MD).18
Quality control measures included negative and positive controls for genotype on each 
plate.18 In addition, duplicates for approximately 10% of DNA samples were selected for re-
sampling. As previously reported, concordance between duplicate samples was high for all 
SNPs (κ > 90%).18,20,21,30 Laboratory personnel were blinded to case-control status and 
duplicate sample status.
Statistical methods
Our study examined associations between tertiles of traffic-related PAH exposure (years 
1995 and 1960–1990) and breast cancer incidence within strata of NER and BER 
polymorphisms. We evaluated PAH exposures for the year 1995 in order to maximize 
statistical power for gene-environment interaction analyses. We also evaluated 1960–1990 
exposure estimates, as these may be a more accurate reflection of long-term exposure 
opportunity. We chose a categorical exposure variable because of the previously reported 
non-linear relationship between traffic PAHs and breast cancer incidence in the LIBCSP12. 
While our previous study compared the top 5% of traffic PAH exposures to those below the 
median, the current gene-environment interaction analysis did not have sufficient statistical 
power to use those categories. We therefore evaluated tertiles of exposure. This maximizes 
study power and is similar to the effect modification analyses from our main effects paper, 
which also collapsed exposure categories.12
We used unconditional logistic regression to estimate odds ratios (ORs) and 95% confidence 
intervals (CIs).32 Trend tests (n = 45) were conducted within stratified models, and 
likelihood ratio tests (n = 18) were used to assess multiplicative interactions between traffic 
PAHs and SNPs.33 We also calculated additive interactions between tertiles of 1995 traffic 
exposure and DNA repair polymorphisms in relation to breast cancer.34 When evaluating 
1960–1990 exposures, effect estimates and confidence limits were combined across 30 
imputed data sets using Rubin’s rules.35 Statistical analyses were conducted using SAS 
version 9.3 (SAS Institute, Cary, NC). No adjustment for multiple comparisons was made, 
given that the panel of polymorphisms we considered was selected based on biologic 
plausibility. To better understand the relationship between assigned PAH exposure and the 
availability of blood samples for genetic testing, we evaluated whether blood donation (yes 
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vs. no) among eligible participants was related to the completeness of their residential 
histories (≤20% vs. >20% missing traffic PAH exposure). We report a positive association 
between blood donation status and the completeness of residential traffic PAH exposure 
(data not shown).
Potential confounders (educational attainment (less than high school, high school graduate, 
some college, college graduate, or post-college), annual household income (<$15,000, 
$15,000–$49,999, $50,000–$69,999, $70,000–$89,999, or $90,000+), race (White, Black, or 
other), religion (none, Protestant, Catholic, Jewish, or other), parity (continuous), age at first 
birth (continuous), body mass index (kg/m2, continuous), duration of oral contraceptive use 
(continuous), lifetime average alcohol intake (never drinkers, <15 g/day, 15–30 g/day, 30+ g/
day), lifetime average physical activity (in hours per week: none, low, average, and high), 
and duration of breastfeeding (continuous)) were identified by a thorough literature review 
and analysis of causal diagrams.12,36 Smoking and dietary sources of PAHs were not 
considered as confounders, because analysis of causal diagrams36 did not support the 
inclusion of smoking and dietary PAH intake in minimally sufficient adjustment sets. No 
covariates were retained using the 10% change in estimate criterion33 relative to age-
adjusted models.12 Hence, regression models are adjusted only for the frequency matching 
factor, five-year age group.
Participants with heterozygous, variant homozygous, and homozygous major genotypes 
were considered separately in our study. We chose this approach because there was no a 
priori reason to combine women with heterozygous and variant homozygous genotypes into 
a single group, and because previous LIBCSP reports evaluating interactions between DNA 
repair polymorphisms and PAH-related exposures suggested differences between 
participants with heterozygous and variant homozygous genotypes that were not present 
when evaluating the main effects of these SNPs on breast cancer incidence.18,21 However, 
participants with heterozygous and variant homozygous genotypes were combined when 
tertile-specific cell sizes comprised fewer than 10 cases and 10 controls.37
Finally, we evaluated linkage disequilibrium (LD) among individual SNPs showing some 
evidence of interactions with traffic PAHs38: ERCC2 Lys751Gln, XRCC1 Arg194Trp and 
Arg399Gln, and OGG1 Ser326Cys. Of these, only the two XRCC1 variants were in LD with 
each other. Using a previously reported method,18,19 we examined traffic-breast cancer 
associations stratified according to the number of ’high-risk’ alleles (0–1, 2–3, ≥4) from the 
following SNPs: ERCC2 Lys751Gln (Gln), XRCC1 Arg194Trp (Trp), and OGG1 
Ser326Cys (Ser).
Results
The number of LIBCSP participants with available exposure estimates varied according to 
the traffic PAH exposure definition (1995 vs. 1960–1990 estimates) and the imputed data set 
(some women were not included in all 30 imputed data sets because they exceeded the 20% 
limit on imputation percentage for certain imputation draws). Sample size also varied by the 
SNP considered (XPA, ERCC2, ERCC4, ERCC5, ERCC1, OGG1, and XRCC1). The study 
population size with SNP assays completed varied as follows: 1995 traffic estimates, 842–
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905 cases and 911–958 controls; 1960–1990 traffic estimates, 332–429 cases and 368–474 
controls (Tables 1 and 2).
Among women with available genotyping data, ORs for the association between traffic 
exposure (highest vs. lowest tertile) and breast cancer incidence were 1.01 (95% CI: 0.81, 
1.26) and 1.04 (95% CI: 0.81, 1.33) for 1995 and 1960–1990 exposures, respectively. We 
present associations between traffic PAHs and breast cancer incidence within strata of DNA 
repair polymorphisms in Tables 1 and 2.
The association between vehicular traffic exposure in 1995 and breast cancer incidence was 
of larger magnitude and greater precision among women with the homozygous variant 
genotype for the ERCC2 Lys751Gln polymorphism: OR (highest vs. lowest tertile) = 2.09 
(95% CI: 1.13, 3.90; p for trend = 0.02) (Table 1). Among women with the homozygous 
major or heterozygous genotypes, the corresponding ORs were 0.86 (95% CI: 0.60, 1.24) 
and 0.94 (95% CI: 0.68, 1.31), respectively (p-interaction = 0.04). Likewise, only the 
ERCC2 Lys751Gln variant showed evidence of super-additive interaction with 1995 traffic 
PAHs (relative excess risk due to interaction [RERI] = 0.32, 95% CI: 0.074, 0.57). We 
present a joint classification table showing the separate and combined effects of 1995 traffic 
PAH exposure and this ERCC2 polymorphism on breast cancer risk in the Supporting 
Information (Table S1). Results for this SNP were similar, though less precise, when 
evaluating cumulative exposure for the years 1960–1990 (Table 2).
Although there was no formal evidence for multiplicative interaction, the relationship 
between 1960–1990 traffic exposure and breast cancer incidence was also stronger among 
women with: at least one variant allele for the XRCC1 Arg194Trp polymorphism (OR = 
3.04, 95% CI:0.97, 9.51; p for trend = 0.049, p-interaction = 0.30); the homozygous major 
genotype for XRCC1 Arg399Gln (OR = 1.88, 95% CI: 1.04, 3.41; p for trend = 0.04, p-
interaction = 0.59); and the homozygous major genotype for OGG1 Ser326Cys (OR = 1.77, 
95% CI: 1.09, 2.88; p for trend = 0.02, p-interaction = 0.52) (Table 2). The results were 
similar, but less precise and of smaller magnitude, when evaluating 1995 exposures (Table 
1).
We found no evidence of interactions between traffic PAHs and the following SNPs: XPA –
4A/G, ERCC4 Arg415Gln, ERCC5 Asp1104His, ERCC1 8092C/A, and ERCC2 
Asp312Asn. This lack of heterogeneity within genotype strata was evident regardless of 
whether we considered traffic PAHs estimated for 1995 (Table 1) or 1960–1990 (Table 2).
We examined the associations between traffic PAHs (highest vs. lowest tertile) and breast 
cancer incidence stratified by the number of high-risk alleles in ERCC2 (Lys751Gln), 
XRCC1 (Arg194Trp), and OGG1 (Ser326Cys). These SNPs were selected based on results 
presented in Tables 1 and 2 and a linkage disequilibrium analysis. The ORs were strongest 
among women with 4 or more ’high-risk’ variants (1995: OR = 2.32, 95% CI: 1.22, 4.49, p 
for trend = 0.011; 1960–1990: OR = 2.96, 95% CI: 1.06, 8.21, p for trend = 0.031), with no 
Additional Supporting Information may be found in the online version of this article.
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clear evidence of a positive association among those with fewer (0–1 or 2–3) high-risk 
variants (Table 3).
Discussion
In the first breast cancer study to evaluate interactions between vehicular traffic and DNA 
repair polymorphisms, the estimated association between traffic exposure (upper vs. lower 
tertiles) and breast cancer incidence was of two-fold greater magnitude among women with 
the homozygous variant genotype for the ERCC2 Lys751Gln polymorphism, and 
multiplicative interaction was evident. Our finding is consistent with the existing literature 
regarding ERCC2, PAH exposures, and breast cancer risk.18,21,39 In addition, although 
formal statistical evaluation did not indicate evidence for multiplicative interaction, the 
association between long-term traffic exposure and breast cancer incidence was of three-fold 
greater magnitude among those with the homozygous major genotype for XRCC1 
Arg399Gln, and of nearly two-fold greater magnitude among women with the homozygous 
major genotype for OGG1 Ser326Cys or with at least one variant allele for XRCC1 
Arg194Trp. However, for the latter, the associated confidence intervals were wide. If 
replicated, our findings may have public health significance due to wide-spread exposure to 
traffic emissions worldwide.
Air pollution, an important PAH source,5,6 has been associated with breast cancer incidence 
in other population studies.10,11 The LIBCSP previously reported positive associations 
between trafic PAHs and breast cancer incidence among biologically plausible subgroups of 
women, including those with very high long-term exposures, hormone-receptor negative 
breast tumors, or low intake of fruits/vegetables.12
PAHs damage DNA by causing bulky adducts13 and oxidative lesions,16 and the resulting 
damage can be repaired through NER and BER pathways.13,16,17,40 NER is a complex 
process involving many proteins, including XPA, which recognizes DNA damage, and 
ERCC2, which unwinds DNA at the lesion site; ERCC1, ERCC4 and ERCC5 excise the 
damaged nucleotide fragment.40 Proteins involved in BER include OGG1, which recognizes 
DNA damage and removes the damaged nucleotide, and XRCC1, a scaffolding protein.17 
Functional variants in the DNA repair genes encoding these proteins may modify 
associations between traffic PAHs and breast cancer risk.14
Studies evaluating the main effects of DNA repair genotypes on breast cancer incidence 
report inconsistent associations for most NER and BER polymorphisms.18,19,41 Variants in 
ERCC2 are more consistently related to breast cancer, including in several meta-
analyses.42,43 The LIBCSP likewise reports modest positive associations between breast 
cancer incidence and polymorphisms in ERCC2,18,21 but not other NER or BER 
genes.18,20,30
Our study found that the association between vehicular traffic exposure and breast cancer 
incidence was of two times greater magnitude among women with the homozygous variant 
genotype for the ERCC2 Lys751Gln polymorphism. This is consistent with a previous report 
from our study population, which observed that the association between breast cancer and 
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variant allele homozygosity for this SNP was limited to those with PAH-DNA adduct levels 
above the median and to current smokers.21 The Lys751Gln polymorphism is also linked to 
PAH-related DNA damage in other epidemiological studies,44,45 including increased levels 
of PAH-DNA adducts in breast tissue.39 Hence, the literature regarding PAH-related 
exposures, the ERCC2 Lys751Gln polymorphism, and breast cancer risk, while limited, has 
been consistent to date.7
In contrast, associations with other NER and BER variants have been inconsistently 
reported. For example, we observed that effect estimates for the relationship between traffic 
PAHs and breast cancer incidence were 3-fold higher among women with the homozygous 
major genotype for the XRCC1 Arg399Gln polymorphism, consistent with a study which 
reported an inverse association between the variant allele for this SNP and PAH-DNA 
adducts in lung tissue.46 However, the LIBCSP investigators have previously reported 
positive associations between the variant XRCC1 – 399Gln allele and breast cancer 
incidence among women with detectable PAH-DNA adducts and among never smokers.20
We also report associations of nearly two-fold greater magnitude between traffic exposure 
and breast cancer incidence among women with at least one variant allele for the XRCC1 
Arg194Trp polymorphism and among those with the homozygous major genotype for the 
OGG1 Ser326Cys polymorphism, although multiplicative interaction was not evident. 
Previous studies found no evidence of interactions between these polymorphisms and active 
smoking (OGG1, XRCC1) or PAH-DNA adducts (XRCC1).20,30 Consistent with our results, 
epidemiologic studies reported positive associations between the variant XRCC1 Trp194Arg 
SNP and micronucleus frequencies among coke oven workers, who are exposed to high 
levels of PAHs,47 as well as PAH-DNA adducts in lung tissue.46 However, only the variant 
OGG1 Ser326Cys polymorphism has been linked to DNA damage endpoints, such as 
oxidative DNA lesions,48 in several investigations.49,50
Our results for polymorphisms in XRCC1 and OGG1 were of greater magnitude when 
evaluating 1960–1990 traffic PAH estimates relative to estimates for 1995. This may be due 
to the smaller sample size of the 1960–1990 dataset, which could decrease the stability of 
results. An alternative explanation is that the 1960–1990 traffic exposure estimates likely 
represent participants’ true long-term exposure more accurately than the 1995 estimates.
Finally, we report no evidence of multiplicative interactions between traffic PAHs and SNPs 
in XPA, ERCC4, ERCC5, ERCC1, and ERCC2 (Asp312Asn only) in relation to breast 
cancer incidence. These findings are consistent with a previous LIBCSP report evaluating 
interactions between PAH-DNA adducts, smoking, and polymorphisms in XPA, ERCC4, 
and ERCC5 with respect to breast cancer incidence.18 Our latter study reported evidence of 
interactions between PAH-DNA adducts, but not active or passive smoking, and the ERCC1 
8092C/A and ERCC2 Asp312Asn SNPs.18
These inconsistencies in the literature could be due in part to the use of different PAH 
exposure surrogates across studies: we evaluated air pollution, while other investigations 
focused on cigarette smoking and PAH-DNA adducts. This complicates interpretation of 
study results, as PAH sources vary with regard to a range of properties, including exposure 
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levels and pathways, particle size, and co-pollutants.4 Differing results across sources of 
PAH exposure may also suggest a more complicated role for certain polymorphisms. For 
example, DNA repair genes encode repair proteins and polymorphisms in these genes may 
therefore affect repair activity levels14; such differences could be of varying importance 
given lower- and higher-level PAH exposures. Finally, variations in study methodology, 
exposure and outcome definitions, and participant characteristics, as well as possible chance 
findings, may underlie inconsistent findings.
Interpretation of our study results requires careful consideration of our study limitations as 
well as our strengths. Our study had limited power for evaluating lower level interactions, 
particularly when examining long-term traffic exposures, which increases the likelihood of 
both false positive and false negative findings.33 We also did not have sufficient statistical 
power to evaluate interactions between DNA repair polymorphisms and high-level 
residential traffic exposures among the most highly exposed 1–5% of study subjects,12 due 
to sample size constraints within genetic subgroups. This may have attenuated or obscured 
some associations. In addition, our results were not adjusted for multiple comparisons. 
However, we used a targeted pathway approach in carefully selecting NER and BER 
polymorphisms that were likely to interact with traffic PAH exposures.13,16
As previously reported, blood donation among participants is positively associated with 
white race, alcohol intake, hormone replacement therapy use, lactation history, and 
mammography, negatively associated with former smoking and age, and unrelated to case-
control status.22 The current study also reports a positive association between blood 
donation and completeness of participants’ residential histories. This may affect the 
generalizability of our findings, but not the internal validity of this study.
Ours is the first study to evaluate the impact of variation in DNA repair genes on the 
association between breast cancer incidence and air pollution, a ubiqutious and generalizable 
exposure source.3 It is one of only a small number of breast cancer studies to examine 
interactions between DNA repair variants and any PAH-related exposure.18–21 Thus, we 
believe our investigation is an important addition to the sparse literature for this topic. 
Furthermore, our results for the ERCC2 Lys751Gln SNP are consistent with the growing 
literature regarding this DNA repair gene, PAH exposures, and breast cancer incidence, 
which increases confidence in our findings.18,21,39 Other strengths of our study include the 
use of a sophisticated, validated model to reconstruct historical traffic exposures,27,29 and 
extensive quality control procedures which were implemented for genotyping assays and 
questionnaire data.18,22 Furthermore, previously reported sensitivity analyses in our study 
population indicate that our findings are robust to altering the percentage of imputed 
exposure and the specific imputation method,12 increasing confidence in our exposure 
estimates.
In summary, associations between vehicular traffic and breast cancer were >2-fold among 
women with ERCC2 Lys751Gln homozygous variants, with strong evidence for 
multiplicative interaction. In addition, we observed 2- to 3-fold greater among women with 
polymorphisms in XRCC1 and OGG1, and when we considered ERCC2, XRCC1, and 
OGG1 variants together, although confidence intervals were wide and there was only 
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suggestive evidence for multiplicative interactions. This is the first breast cancer study to 
examine the interactions between air pollution and DNA repair polymorphisms, and our 
findings require confirmation in larger studies. Future breast cancer studies should also 
evaluate interactions between traffic exposures and genetic variants in oxidative stress and 
carcinogen metabolizing pathways. Our findings, if confirmed, may help identify women 
who are particularly susceptible to the carcinogenic effects of traffic pollution on the breast, 
and may help clarify mechanisms linking traffic PAHs to breast cancer incidence.
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Polycyclic aromatic hydrocarbons are known carcinogens generated by vehicular traffic. 
They damage DNA by forming adducts or inducing oxidative stress. Here the authors 
examined the association between traffic exposure and breast cancer incidence while 
taking into account different DNA repair genotypes. Cancer risks were elevated in 
women carrying certain DNA repair variants especially when some variants were 
combined. These findings may help identify women who are particularly susceptible to 
the carcinogenic effects of traffic pollution on the breast.
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